“In summary, the deal boils down to Elsevier offering Dutch (corresponding) authors open access publishing options in nearly all of its scientific journals. However, a number of journals from the Cell and Lancet families have been excluded from the deal, for now. Additionally, both sides agreed to work towards the creation of infrastructure for research data and information, and to enter into ‘open science’ projects. All of this comes at a price of € 16.4 million per year.
Going by headlines in the national newspapers, one would get the impression that the Dutch are making a giant step forward on the path to open access and open science. But is this really the case? ScienceGuide asked experts and (co)negotiators and scrutinized the fine print of the contract. As it turns out, parties have agreed on very specific definitions of open access and open science, with vague articles in the agreement to underpin them. Agreements that are at odds with earlier statements on open science and on rewards and recognition….
However, due to the ‘unique’ nature of the contract, no true comparison can be made with other agreements. Not only because various Elsevier tools and platforms are also included in the contract, but especially because of the arrangements around what has become known as ‘Professional Services’. The market value of the ‘open science’ component is, after all, unknown….”